Now Better Searching for Health Professionals

Although a nearly infinite amount of information is nowadays accessible via the Internet, it is not easy to systematically sort out the right information. This problem is addressed by Transinsight GmbH in Dresden, a company that develops knowledge-based search technologies in close cooperation with the Technische Universität Dresden. Now, after a development period of only six months, Transinsight GmbH has created MeSHPubMed, the worldwide first knowledge-based search engine for the medical sciences to be made available on the Internet.

The search platform www.MeSHPubMed.org intelligently searches and, thus, finds the desired results much faster and much more precisely than a standard search engine can. For the first time, the technology for the intelligent search developed by Transinsight GmbH in cooperation with the TU Dresden has been used on the well-known search engine for molecular biologists www.GOPubMed.org.

"Now, medical professionals will be able to work much more efficiently, because they will be able to utilize the search engine MeSHPubMed which sorts the 16 million presently available scientific articles in such a way as is intended by the knowledge network MeSH (Medical Subject Headings), an initiative of the National Library of Medicine, USA," says Dr. Michael R. Alvers, CEO of Transinsight. The search engine allows the search time for relevant scientific information to be drastically reduced. For example, a search for the tumor suppressor protein P53 delivers about 10 million articles through conventional search engines and more than 40,000 articles in the case of standard medical search engines like www.PubMed.org. For the user, it is impossible to browse this quantity of texts. However, with www.MeSHPubMed.org, by means of interactive navigation in the knowledge tree of the MeSH, clicking the hierarchical entries "Diseases" -> "Cardiovascular Diseases" -> "Heart Diseases," means the search results can be restricted so that only six relevant articles are shown. This is a great time saver!

Prof. Dr. Michael Schroeder, co-founder of Transinsight and professor of bioinformatics at the Technische Universität Dresden, is enthused to see the practical use of technologies developed partly within European research projects such as REWERSE, Sealife and EFRE. "We are proud to have developed technologies that reach a speed and precision that currently cannot be achieved by anybody else in the world. Our ultra-fast and very precise algorithms provide an enormous customer benefit: the noticeable shortening of search times! Having already two products online is a good example of a great knowledge transfer between university and industry," says Schroeder.

This fruitful cooperation between Transinsight and the Technische Universität Dresden is based on a cooperation contract. "In Dresden, there is an atmosphere like at Stanford University, at MIT in Boston or at Cambridge University," says Alvers. On this fertile ground, Transinsight GmbH wants to open new horizons. To that end, two new search platforms are already in the beta test. Moreover, with a partner, Transinsight wants to address other areas such as the job search field, because the technology of sorted searching is global and can be used in non-biomedical areas as well.

Related news articles:

About Transinsight
Founded in November 2005, Transinsight is focused on software solutions for the life sciences providing products for knowledge based technologies. The flagship product, GoPubMed, a well established biomedical search engine, was the first knowledge based search engine for the Life Sciences on the Internet. Transinsight is headquartered in one of the leading German biotech incubators, the BioInnovationCenter Dresden BIOZ, where science and business work under one roof. Transinsight works in close collaboration with the Technische Universität Dresden. For further information, visit: http://www.transinsight.com

About REWERSE
The European Network of Excellence REWERSE is a research project on "Reasoning on the Semantic Web". REWERSE develops rule-based languages and applications to intelligently process data on the conventional and the Semantic Web. REWERSE is funded by the European Commission and Switzerland within the 6th Framework Programme, reference number 506779. The project started in March 2004 and runs for four years. REWERSE networks over 100 researches from 27 research and industry organisations in 14 European countries. For further information, visit: http://rewerse.net

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...